Liabilities / Assets
87th percentile
Higher debt load relative to assets than 87% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
87th percentile
Higher debt load relative to assets than 87% of similar nonprofits.
Liabilities / Revenue
88th percentile
Higher debt load relative to revenue than 88% of similar nonprofits.
Net Margin
33rd percentile
Higher net margin than 33% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
34th percentile
Faster asset growth than 34% of similar nonprofits.
Revenue Growth
26th percentile
Faster revenue growth than 26% of similar nonprofits.
Assets
Down$294,728
Down $18,017 (-5.8%) from 2018
Net Assets
Down$199,163
Down $13,676 (-6.4%) from 2018
Liabilities
Down$95,565
Down $4,441 (-4.4%) from 2018
Revenue
Down$413,001
Down $89,077 (-18%) from 2018
Expenses
Down$426,677
Down $122,710 (-22%) from 2018
Net Income
Up-$13,676
Up $33,633 (+71%) from 2018
This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
All activities for research and treatment of Cystic Fibrosis.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2019 • Form 990Summary only. Only limited summary data is available for this year.